 |
Case Report
Massive and unilateral rheumatoid pleural effusion without overt disease
1 Department of Medicine, Faculty of Medicine, Kuwait University, Safat, Kuwait
2 Department of Medicine, Nephrology Unit, Amiri Hospital, Ministry of Health, Kuwait, Kuwait
Address correspondence to:
Kamel El-Reshaid
Professor, Department of Medicine, Faculty of Medicine, Kuwait University, P O Box 24923, 13110 Safat,
Kuwait
Message to Corresponding Author
Article ID: 101277Z01KR2021
Access full text article on other devices
Access PDF of article on other devices
How to cite this article
El-Reshaid K, Al-Bader S. Massive and unilateral rheumatoid pleural effusion without overt disease. Int J Case Rep Images 2021;12:101277Z01KR2021.ABSTRACT
Introduction: Rheumatoid arthritis (RA) is an autoimmune disease that manifests as a progressive mutilating arthritis with rare systemic involvement. The prevalence of its pleuropulmonary manifestations hardly exceeds 5% of cases. The reported ones include: pleurisy, interstitial fibrosis, effusion, rheumatoid nodules, and Caplan’s syndrome. The latter has been described in association with disease activity or as late complications.
Case Report: We present a patient with progressive and unilateral pleural effusion (PE) due to rheumatoid arthritis (RA) yet without overt systemic manifestations of disease which is exceedingly rare. Diagnosis was suspected by an exudative PE that had low glucose (compared to his serum) and pathognomonic cytology. Subsequently, it was confirmed by high anti-cyclic citrullinated peptide (anti-CCP) antibody. The effusion regressed significantly, 1 month later, after Prednisone and Rituximab therapy.
Conclusion: Rheumatoid arthritis should be considered in patients presenting with exudative PE that lacks history of trauma, and manifestations of infection, malignancy, and autoimmune diseases. High anti-CCP and cytological examination are useful in diagnosis.
Keywords: Lung, Pleural effusion, Rheumatoid arthritis, Rituximab
SUPPORTING INFORMATION
Author Contributions
Kamel El-Reshaid - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Shaikha Al-Bader - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Guaranter of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2021 Kamel El-Reshaid et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.
